| 1 |
CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 04.06.2025 |
2025-Jun-04 |
|
617 KB |
| 2 |
Guidance document on disposal of expired/ unused drugs |
2025-May-27 |
|
588 KB |
| 3 |
Office Memorandum regarding Clarification of Comprehensive permission for products imported for overprinting/stickering/stamping as per Rule 104A of Drugs and Cosmetics Rules 1945 |
2025-May-26 |
|
438 KB |
| 4 |
Cancellation of products under RC/COS-003211, for import of Cosmetics under Cosmetics Rules, 2020 |
2025-May-21 |
|
582 KB |
| 5 |
Revised Export NOC Guidance document for Manufacture of Unapproved / Approved New Drugs along with revised Annexures |
2025-May-07 |
|
673 KB |
| 6 |
Inviting comments on Revised Guidelines on Similar Biologics- Regulatory requirements for Marketing Authorization in India, 2025 drafted by CDSCO |
2025-May-06 |
|
1002 KB |
| 7 |
Public Notice on PRO Schedule |
2025-Apr-30 |
|
349 KB |
| 8 |
Manufacturing and marketing of unapproved FDCs regarding |
2025-Apr-11 |
|
223 KB |
| 9 |
Examination of 2nd assessment report of Prof. Kokate Committee by Drugs Technical Advisory Board (DTAB) in its meeting dated 26.09.2022 |
2025-Apr-11 |
|
3102 KB |
| 10 |
Provision for auto-generated Market Standing Certificate and Non-Conviction Certificate for licenced medical device |
2025-Apr-09 |
|
307 KB |
